Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CCR1 | P32246 | 1/20 | 0.32 |
| ▸ | CCR5 | P51681 | 1/20 | 0.32 |
| ▸ | CCR8 | P51685 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22597896 | 0.82 | PARP15 (0.33) | ALDH1A1 | |
| SCHEMBL17338775 | 0.81 | TLR9 (0.31) | ALDH1A1NPC1RAB9A | |
| SCHEMBL17338924 | 0.81 | KLKB1 (0.38) | TP53HTR2AHTR2C | |
| SCHEMBL17811230 | 0.78 | — | — | |
| SCHEMBL17815221 | 0.77 | CCR1 (0.37) | TP53ALDH1A1GFERSMN1; SMN2CCR1 | |
| SCHEMBL17248114 | 0.76 | PDE4B (0.41) | ALDH1A1KDM4E | |
| SCHEMBL20116289 | 0.74 | CCR1 (0.34) | TP53ALDH1A1SMN1; SMN2CCR1CCR5 | |
| SCHEMBL24657617 | 0.71 | TP53 (0.33) | TP53ALDH1A1SMN1; SMN2CCR1CCR5 | |
| SCHEMBL21893418 | 0.71 | KDM4E (0.37) | TP53ALDH1A1SMN1; SMN2CCR1CCR5 | |
| SCHEMBL21358993 | 0.70 | KLKB1 (0.34) | TP53ALDH1A1SMN1; SMN2CCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019209948-A9 | COMPOUNDS AND USES THEREOF | YUMANITY THERAPEUTICS, INC. (US) | 2020-01-02 | — | — | WO | disclosed |
| WO-2019018795-A1 | COMPOUNDS AND USES THEREOF | YUMANITY THERAPEUTICS (US) | 2019-01-24 | — | — | WO | disclosed |
| WO-2018121766-A1 | NITROGEN-CONTAINING FUSED HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND INTERMEDIATE, COMPOSITION, AND APPLICATION THEREOF | 上海医药集团股份有限公司 | 2018-07-05 | — | — | WO | disclosed |
| WO-2018081167-A1 | COMPOUNDS AND USES THEREOF | YUMANITY THERAPEUTICS (US) | 2018-05-03 | — | — | WO | disclosed |